TP53 and acute kidney injury: Previous research has shown that tFNA can modulate the p53 pathway to alleviate acute liver injury and can act as an effective reactive oxygen species (ROS) scavenger for treating AKI.[14a] These findings, combined with the therapeutic potential of miRNA‐125, highlight the promise of using tFNA in synergistic treatments for ALF and AKI.